Schedule One - Superdielectrics Group plc | RNS | Ticker

Schedule One - Superdielectrics Group plc

RNS Announcement

RNS Number : 8772S

AIM

19 November 2021

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Superdielectrics Group plc

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

The Mansion Chesterford Research Park, Little Chesterford, Saffron Walden, England, CB10 1XL

COUNTRY OF INCORPORATION:

England and Wales

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

https://superdielectrics.com/

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

Superdielectrics Group plc ("Superdielectrics" or the "Company") is a company based near Cambridge, UK, focused on developing technology to build supercapacitors with high energy density, low cost, environmentally benign electrical energy storage devices that will help create a clean and sustainable global energy and transportation system.

Superdielectrics was founded in 2012 by Dr. Donald James Highgate and Francis James ("Jim") Heathcote who were joined by Nigel Anthony Spence as Finance Director. The team planned and then implemented a research programme to develop biocompatible, electrically conducting hydrophilic polymers, which had the potential to be used in bioelectronics.

From 2014, working with Surrey University, the team discovered the materials exhibited very unusual electrical properties. In mid-2016, test-samples were sent to Professor David Fermin, Bristol Electrochemistry Group, for independent analysis who confirmed that the Company's superdielectric materials have capacitance values 1,000-10,000 times higher than the then existing aqueous electrolytes in supercapacitors. In short, this means these materials have the potential to create energy storage solutions that store significantly more energy than existing solutions of the same weight.

Therefore, the Company has established that its superdielectric materials could translate into game-changing, commercially viable products, offering a step change in performance compared to existing electrical energy storage technology.

Having completed the University supported research programme, the Company has now relocated to new laboratory facilities near Cambridge with the aim of replicating the results identified in the laboratory, increasing energy density and developing a supercapacitor incorporating the Company's polymers on a commercial scale.

The Company plans to do so through continuing to work on refining its polymers, developing associated production technology and intends (subject to funds raised) to plan, lease and fit out a pilot production plant to exploit the commercial opportunities that this is expected to create.

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

TBC ordinary shares of £0.001 each

Issue price - TBC pence

There are no shares to be held as treasury shares and there are no restrictions as to transfer of the securities.

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

£TBCm on Admission (through a placing of new equity)

Anticipated market capitalisation on Admission: £TBC

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

TBC%

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

None

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

THE BOARD
Mr William Philip Seymour Richards	Non-Executive Chairman
Mr Francis James (Jim) Heathcote	Chief Executive Officer
Dr. Donald James Highgate	Director of Research
Mr Marcus John Scott	Finance Director
Lord Michael Alan Spencer, Lord Spencer of Alresford	Non-Executive Director
Mr Nigel Anthony Spence	Non-Executive Director
Mr Ian Wright	Non-Executive Director
Mr Andrew James Kitchingman	Non-Executive Director

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Shareholder	% before Admission	% on Admission
William Philip Seymour Richards¹	26.52%	TBC%
Francis James (Jim) Heathcote²	24.09%	TBC%
Dr. Donald James Highgate³	24.09%	TBC%
Michael Ulic Anthony Alen-Buckley	6.06%	TBC%
Nigel Anthony Spence⁴	4.31%	TBC%
Lord Michael Alan Spencer, Lord Spencer of Alresford⁵	3.82%	TBC%

¹The holdings of William Philip Seymour Richards are split between his personal holding (6.06%) and RAB Capital Holdings Limited (20.46%), a company which is deemed to be ultimately controlled by William Philip Seymour Richards.

² The holdings of Francis James Heathcote are split between his personal holding (20.49%) and his spouse Susan Heathcote (3.60%).

³The holdings of Dr. Donald James Highgate are split between his personal holding (20.49%) and his spouse Jane Highgate (3.60%).

⁴ The holdings of Nigel Anthony Spence are split between his personal holding (4.27%) and his spouse Christian Spence (0.04%).

⁵ The holdings of Lord Michael Alan Spencer, Lord Spencer of Alresford are split between his personal holding (0.77%) and his investment vehicle, IPGL Limited (3.05%).

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

RAB Capital Holdings Limited

Lloyd Edwards-Jones SAS

Terence Owen Lloyd

Marcus Edwards-Jones

Byron Houdayer

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) The current accounting reference date of the Company is 31 March.

(ii) 31 March 2021

(iii) Accounts for 6 months period ending 30 September 2021 (to be notified by 31 December 2021); Accounts for 12 months period ending 31 March 2022 (by 30 September 2022); Accounts for 6 months period ending 30 September 2022 (by 31 December 2022).

EXPECTED ADMISSION DATE:

Early December 2021

NAME AND ADDRESS OF NOMINATED ADVISER:

WH Ireland Limited,

24 Martin Lane,

London,

EC4R 0DR

NAME AND ADDRESS OF BROKER:

WH Ireland Limited,

24 Martin Lane,

London,

EC4R 0DR

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

Copies of the Admission Document will be available free of charge to the public during normal business hours on any day (Saturdays, Sundays and public holidays excepted) at the offices of WH Ireland Limited, 24 Martin Lane, London, EC4R 0DR in accordance with the AIM Rules. The Admission Document will also be available for download from the Company's website at https://superdielectrics.com/

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

The QCA Corporate Governance Code, as published by the Quoted Companies Alliance.

DATE OF NOTIFICATION:

19 November 2021

NEW/ UPDATE:

NEW

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PAAFLFSELVLTLIL

RNS metadata

Title: Schedule One - Superdielectrics Group plc
Time: 08:00:01
Date: 19 Nov 2021
Category: Capital structure
ID: 8772S